LifeNet Health Launches Bone Void Solution, PliaFX Flo

LifeNet Health has added PliaFX Flo to its PliaFX portfolio of advanced fiber demineralized bone matrices. PliaFX Flo is available through Johnson & Johnson MedTech and the LifeNet Health Orthobiologics strategic services team. 

PliaFX Flo is engineered to amplify healing potential, delivering greater confidence to surgeons and better outcomes for patients. This next-generation bone void solution, now in a pre-filled syringe format, offers surgeons enhanced precision and handling, streamlining its application for spine and orthopedic procedures.

The new syringe format allows for the product’s ease of use for efficient, one-step application that reduces OR preparation time. This detail underscores LifeNet Health’s commitment to advancing grafting solutions that prioritize both surgical precision and patient well-being.

“With PliaFX Flo, we are expanding the possibilities for fusion, making natural healing more efficient than ever,” said Richard Rice, Vice President of Orthopedics and CMF at LifeNet Health. “Our fiber technology provides a uniquely natural, versatile approach to bone fusion, delivering surgeons a new level of control and effectiveness in the operating room.”

Built using LifeNet Health’s proprietary PliaFX Advanced Fiber technology, PliaFX Flo combines the strength of natural bone with unmatched handling and moldability. Its microhook fiber structure is made to promote a natural fusion process, optimizing the body’s regenerative response while supporting reliable integration and retention.

PliaFX Flo is the latest addition to the PliaFX family, which includes PliaFX Prime—the premier 100% bone fiber Demineralized Bone Matrix (DBM) —and PliaFX Pak, which extends a full spectrum of grafting options.